Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.11.22.568352

Efficient Memory Encoding Explains the Interactions Between Hippocampus Size, Individual Experience, and Clinical Outcomes: A Computational Model

Abstract

The relationship between hippocampal volume and memory function has produced mixed results in neuroscience research, which suggests an additional influencing mechanism. To explore the role of an experience-dependent encoding mechanism, we developed an autoencoder model of the cortex-hippocampus loop and examined how its memory representation is affected by a penalty that prioritizes sparseness. We trained our model with the Fashion MNIST database and a loss function to modify synapses via backpropagation of mean squared recall error. The model exhibited experience-dependent efficient encoding, representing frequently-repeated objects with fewer neurons and smaller loss penalties; representations of similar sizes were found for objects repeated equally. Our findings clarify perplexing results from neurodevelopmental studies by linking increased hippocampal size and memory impairments in autism spectrum disorder (ASD) to decreased sparseness, and explaining dementia symptoms of forgetting with varied neuronal integrity. Our findings propose a novel model that connects observed relationships between hippocampal size and memory to the environmental demands and the underlying biological constraints, contributing to the development of a larger theory on experience-dependent encoding and storage and its failure. Author SummaryThe hippocampus is the brain region where memories are initially formed. A larger hippocampus seems to be associated with better memory performance, but this is not a static relationship; studies suggest that its size might grows with demand (e.g., the need to memorize more information) and that, in certain conditions, larger or smaller volumes of the hippocampus are not associated with better or worse memory. We demonstrate that it is possible to make sense of these findings by assuming that the hippocampus balances the need to correctly remember with the need to minimize resources used to store it, and that the hippocampal size might change as a function of memory demands (the characteristics of the information to memorize) and the underlying biology (e.g., the presence of hippocampal cell damage, or a reduction in hippocampal GABA receptors). We test this hypothesis by building a neural network model; the model correctly predicts existing, puzzling findings in the literature, and can even capture subtle interactions between different phenomena, such as predicting that individuals with Autism Spectrum Disorder would be more susceptible to memory loss in dementia.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Stocco, A., Smith, B. M., Leonard, B., Hake, H. S.. 2023-11-22. Efficient Memory Encoding Explains the Interactions Between Hippocampus Size, Individual Experience, and Clinical Outcomes: A Computational Model. https://doi.org/10.1101/2023.11.22.568352

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗